Improved methods of AAV-mediated gene targeting for human cell lines using ribosome-skipping 2A peptide

被引:13
作者
Karnan, Sivasundaram [1 ]
Ota, Akinobu [1 ]
Konishi, Yuko [1 ]
Wahiduzzaman, Md [1 ]
Hosokawa, Yoshitaka [1 ]
Konishi, Hiroyuki [1 ]
机构
[1] Aichi Med Univ, Sch Med, Dept Biochem, Nagakute, Aichi 4801195, Japan
基金
日本学术振兴会;
关键词
HUMAN CANCER-CELLS; ADENOASSOCIATED VIRUS VECTORS; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; ZINC-FINGER NUCLEASES; DOUBLE-STRAND BREAKS; EPITHELIAL-CELLS; SOMATIC-CELLS; PIG-A; GENOME; EXPRESSION;
D O I
10.1093/nar/gkv1338
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The adeno-associated virus (AAV)-based targeting vector has been one of the tools commonly used for genome modification in human cell lines. It allows for relatively efficient gene targeting associated with 1-4-log higher ratios of homologous-to-random integration of targeting vectors (H/R ratios) than plasmid-based targeting vectors, without actively introducing DNA double-strand breaks. In this study, we sought to improve the efficiency of AAV-mediated gene targeting by introducing a 2A-based promoter-trap system into targeting constructs. We generated three distinct AAV-based targeting vectors carrying 2A for promoter trapping, each targeting a GFP-based reporter module incorporated into the genome, PIGA exon 6 or PIGA intron 5. The absolute gene targeting efficiencies and H/R ratios attained using these vectors were assessed in multiple human cell lines and compared with those attained using targeting vectors carrying internal ribosome entry site (IRES) for promoter trapping. We found that the use of 2A for promoter trapping increased absolute gene targeting efficiencies by 3.4-28-fold and H/R ratios by 2-5-fold compared to values obtained with IRES. In CRISPR-Cas9-assisted gene targeting using plasmid-based targeting vectors, the use of 2A did not enhance the H/R ratios but did upregulate the absolute gene targeting efficiencies compared to the use of IRES.
引用
收藏
页数:14
相关论文
共 54 条
  • [1] GENE TARGETING IN NORMAL SOMATIC-CELLS - INACTIVATION OF THE INTERFERON-GAMMA RECEPTOR IN MYOBLASTS
    ARBONES, ML
    AUSTIN, HA
    CAPON, DJ
    GREENBURG, G
    [J]. NATURE GENETICS, 1994, 6 (01) : 90 - 97
  • [2] Promoter less gene targeting without nucleases ameliorates haemophilia B in mice
    Barzel, A.
    Paulk, N. K.
    Shi, Y.
    Huang, Y.
    Chu, K.
    Zhang, F.
    Valdmanis, P. N.
    Spector, L. P.
    Porteus, M. H.
    Gaensler, K. M.
    Kay, M. A.
    [J]. NATURE, 2015, 517 (7534) : 360 - U476
  • [3] Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin
    Brodsky, RA
    Mukhina, GL
    Li, SY
    Nelson, KL
    Chiurazzi, PL
    Buckley, JT
    Borowitz, MJ
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (03) : 459 - 466
  • [4] Targeting DNA Double-Strand Breaks with TAL Effector Nucleases
    Christian, Michelle
    Cermak, Tomas
    Doyle, Erin L.
    Schmidt, Clarice
    Zhang, Feng
    Hummel, Aaron
    Bogdanove, Adam J.
    Voytas, Daniel F.
    [J]. GENETICS, 2010, 186 (02) : 757 - U476
  • [5] A Comparative Analysis of Constitutive Promoters Located in Adeno-Associated Viral Vectors
    Damdindorj, Lkhagvasuren
    Karnan, Sivasundaram
    Ota, Akinobu
    Hossain, Ekhtear
    Konishi, Yuko
    Hosokawa, Yoshitaka
    Konishi, Hiroyuki
    [J]. PLOS ONE, 2014, 9 (08):
  • [6] Gene Therapy Using Adeno-Associated Virus Vectors
    Daya, Shyam
    Berns, Kenneth I.
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2008, 21 (04) : 583 - 593
  • [7] Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome
    DeKelver, Russell C.
    Choi, Vivian M.
    Moehle, Erica A.
    Paschon, David E.
    Hockemeyer, Dirk
    Meijsing, Sebastiaan H.
    Sancak, Yasemin
    Cui, Xiaoxia
    Steine, Eve Line J.
    Miller, Jeffrey C.
    Tam, Phillip
    Bartsevich, Victor V.
    Meng, Xiangdong
    Rupniewski, Igor
    Gopalan, Sunita M.
    Sun, Helena C.
    Pitz, Kathleen J.
    Rock, Jeremy M.
    Zhang, Lei
    Davis, Gregory D.
    Rebar, Edward J.
    Cheeseman, Iain M.
    Yamamoto, Keith R.
    Sabatini, David M.
    Jaenisch, Rudolf
    Gregory, Philip D.
    Urnov, Fyodor D.
    [J]. GENOME RESEARCH, 2010, 20 (08) : 1133 - 1142
  • [8] Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus
    Di Nicolantonio, Federica
    Arena, Sabrina
    Tabernero, Josep
    Grosso, Stefano
    Molinari, Francesca
    Macarulla, Teresa
    Russo, Mariangela
    Cancelliere, Carlotta
    Zecchin, Davide
    Mazzucchelli, Luca
    Sasazuki, Takehiko
    Shirasawa, Senji
    Geuna, Massimo
    Frattini, Milo
    Baselga, Jose
    Gallicchio, Margherita
    Biffo, Stefano
    Bardelli, Alberto
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (08) : 2858 - 2866
  • [9] Replacement of normal with mutant alleles in the genome of normal human cells unveils mutation-specific drug responses
    Di Nicolantonio, Federica
    Arena, Sabrina
    Gallicchio, Margherita
    Zecchin, Davide
    Martini, Miriam
    Flonta, Simona Emilia
    Stella, Giulia Maria
    Lamba, Simona
    Cancelliere, Carlotta
    Russo, Mariangela
    Geuna, Massimo
    Appendino, Giovanni
    Fantozzi, Roberto
    Medico, Enzo
    Bardelli, Alberto
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (52) : 20864 - 20869
  • [10] Zinc-finger nuclease-mediated gene correction using single AAV vector transduction and enhancement by Food and Drug Administration-approved drugs
    Ellis, B. L.
    Hirsch, M. L.
    Porter, S. N.
    Samulski, R. J.
    Porteus, M. H.
    [J]. GENE THERAPY, 2013, 20 (01) : 35 - 42